Skip to main content

#153650

Anti-Growth Differentiation Factor 9B [28A]

Cat. #153650

Anti-Growth Differentiation Factor 9B [28A]

Cat. #: 153650

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Growth Differentiation Factor 9B

Class: Monoclonal

Application: ELISA ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BioServ UK Ltd

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Growth Differentiation Factor 9B [28A]
  • Alternate name: Bone morphogenetic protein 15, BMP-15, Growth/differentiation factor 9B, GDF9B
  • Research fields: Cancer;Developmental biology
  • Clone: 28A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 55 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; WB
  • Description: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.
  • Immunogen: Recognizes sequence SAEVTASSSKHSGPENNQC on the C-terminus of human GDF9B (BMP15)
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Growth Differentiation Factor 9B
  • Molecular weight: 55 kDa
  • Target background: BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.

Applications

  • Application: ELISA ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence.
  • Sudiman et al. 2014. PLoS One. 9(7):e103563. PMID: 25058588.
  • Al-Musawi et al. 2013. Endocrinology. 154(2):888-99. PMID: 23284103.
  • Species differences in the expression and activity of bone morphogenetic protein 15.
  • Pulkki et al. 2011. Mol Cell Endocrinol. 332(1-2):106-15. PMID: 20937357.
  • The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.